Le Lézard
Classified in: Health, Science and technology, Business, Covid-19 virus
Subjects: PDT, VEN

Genobank Surpasses $418K in Crowdfunding to Launch the First Ever Anonymous DNA Test Kit


PALO ALTO, Calif., July 14, 2020 /PRNewswire/ -- Genobank.io, the first ever anonymous, privacy-preserving DNA extraction kit announced that it has reached $418,000 in crowdfunding from over 1,400 investors around the world. The crowdfunding opportunity allows a majority of the world's population to invest as little as $100 in the company in exchange for equity. The investment will enable Genobank.io to offer their DNA test kits to be branded and sponsored by key research institutions. This news is joined by the announcement that Genobank.io has been awarded a $50K grant by VC fund Block.one to use its technology in facilitating anonymous access to COVID-19 testing.

Genobank.io is dedicated to helping individuals in claiming ownership over their exclusive genetic variants while making them available for analysis. According to a study from KPMG, about 65% of people who are interested in taking a DNA test have worries about privacy. For the first time ever, Genobank.io allows individuals to have their DNA encrypted & stored with confidence and have the option to be compensated by participating in genome-guided clinical trials or health studies using a Blockchain based data wallet.

"In 2017 my son was diagnosed with a rare genetic disorder caused by a mutation in his DNA. After looking into various personal genetics companies, I was alarmed at the control they would have over my sons precious DNA. This motivated us to create a solution that puts the power back into consumers hands." - Daniel Uribe, CEO, Genobank.io

The company's patent pending technology leverages blockchain and differential privacy to guarantee consumers security and control over humanity's most precious asset: our DNA. In June 2020, the British Blockchain Association approved and published groundbreaking research that was conducted by Genobank.io's CEO, Daniel Uribe and Gisele Waters, PhD: "Privacy Laws, Genomics and Non-Fungible-Tokens".

To support Genobank's mission to provide the world with control over their DNA and gain a financial stake in their success, visit their equity crowdfunding campaign on Republic (https://republic.co/genobank-io).

SOURCE Genobank.io


These press releases may also interest you

at 02:25
Kyocera Corporation (TOKYO:6971) today announced its consolidated financial results for the fiscal year ended March 31, 2024 ("fiscal year 2024" or the "period"), as summarized below. Complete details are available at:...

at 02:16
Highlights of the first quarter of 2024 Net sales amounted to SEK 31,077m (32,734). Organic sales decreased by 3.7% mainly driven by negative price. Weaker market demand resulted in lower volumes for the Group except in Latin America where increased...

at 02:16
First quarter 2024 3 per cent organic revenue growth (using fixed exchange rates and a comparable group structure)Net sales increased by 1 per cent to 1,299.9 MEUR (1,286.6)Net sales including the reduction of acquired deferred revenue amounted to...

at 02:15
Mitsubishi Electric Corporation (TOKYO: 6503) announced today its consolidated financial results for fiscal 2024 (April 1, 2023 - March 31, 2024). The full document on Mitsubishi Electric's financial results can be viewed at the following link:...

at 02:11
Xiao-I Corporation ("Xiao-I" or "the Company"), a leading artificial intelligence company, announced today that that the Company's full year 2023 financial results will be released before the U.S. market opens on Tuesday April 30, 2024. The Company...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...



News published on and distributed by: